Gedeon Richter Ltd/ HU0000123096 /
7/19/2024 9:14:35 PM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
27.1736USD | - | 3 Turnover: 81.5208 |
-Bid Size: - | -Ask Size: - | 5.55 bill.USD | - | - |
GlobeNewswire
5/3
Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the c...
GlobeNewswire
1/26/2022
Myovant Sciences Announces Financial Results for Third Quarter of Fiscal Year 2021 and Corporate Upd...
GlobeNewswire
1/10/2022
Myovant Sciences Announces Preliminary Financial Results for Third Quarter of Fiscal Year 2021
GlobeNewswire
10/26/2021
Myovant Sciences Announces Financial Results for Second Quarter of Fiscal Year 2021 and Corporate Up...
GlobeNewswire
7/28/2021
Myovant Sciences Announces Financial Results for First Quarter of Fiscal Year 2021 and Corporate Upd...
GlobeNewswire
7/20/2021
Myovant Sciences Announces European Commission Approval for RYEQO® for the Treatment of Women With U...
GlobeNewswire
5/21/2021
Myovant Sciences Receives Positive CHMP Opinion for RYEQO® (Relugolix Combination Tablet) for the Tr...
GlobeNewswire
5/11/2021
Myovant Sciences Announces Corporate Updates and Financial Results for Fourth Fiscal Quarter and Fis...
GlobeNewswire
2/11/2021
Myovant Sciences Announces Corporate Updates and Financial Results for Third Quarter of Fiscal Year ...
GlobeNewswire
11/12/2020
Myovant Sciences Announces Corporate Updates and Financial Results for Second Quarter Fiscal Year 20...
GlobeNewswire
8/11/2020
Myovant Sciences Announces Corporate Updates and Financial Results for First Quarter Fiscal Year 202...
GlobeNewswire
5/18/2020
Myovant Sciences Provides Recent Corporate Updates and Reports Financial Results for Fourth Fiscal Q...
GlobeNewswire
3/31/2020
Myovant Sciences and Gedeon Richter Enter into Exclusive License Agreement to Commercialize Relugoli...
GlobeNewswire
7/5/2019
Global Osteoporosis Market & Drug Outlook 2017-2027: Current Market Leader Prolia Will Make Way for ...
GlobeNewswire
3/5/2019
Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Yea...
GlobeNewswire
2/5/2019
Easton Announces Updates on Its $2,600,000 Framing Contract to Construct 150 Homes as Well as Other ...
GlobeNewswire
1/23/2019
Easton Announces Completion of Financial Statements With $200,000 in Sales in Quarter Ending Sept. 3...
GlobeNewswire
1/11/2019
Easton Announces Status Updates on its $2,600,000 Framing Contract to Construct 150 Homes, Including...
GlobeNewswire
1/2/2019
Easton Pharmaceuticals Announces Signing and Commencement of $2,600,000 Framing Contract to Construc...